chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Adacel TDaP given IM prior to planned d/c home 3/6/15 at 1714. At her vax reassessment at 1744 the pt reported nausea and btwn then and 1800 was dry heaving. After a walk and cooling down nausea persisted and MD was notified- Zofran order was obtained. Zofran PO was given @ 1815 and pt immediately vomited. She vomited 3 times within the next 30 mins, temp was 97.6. Pt reports chills starting @ 2145 after her shower. Vomiting continued til 2200. Temps following were: 2210: 99.4, 0215: 99.2, 0540: 99.4 (none prior exceeded 98.2)- BPs remained within normal range of pt prior to IM vaccine.  Headache started @ 0200 (rated 8/10 at am assessment), Tylenol was given @ 0744 and pt reported resolution of h/a and sweating a lot during her morning nap following the med.
This spontaneous report was received from a pharmacist refers to a patient of an unknown age and gender. The patient's concurrent condition, medical history and concomitant medications were not reported. The patient was vaccinated with ZOSTAVAX on 27-AUG-2014 and 24-SEP-2015. No adverse symptoms were reported. Additional information has been requested.
Very sore arm for 4 days following vaccine and then on day 9 redness and itching the size of a quarter?not known yet how long this will last.
light headness( Mediately )sore-arm. Swelling breast, sore abdomen, wheezing every thing else 1 hour after.
Patient states about 3 hours after receiving vaccine she had red, raised, burning, stinging red bumps all over her body that looked similar to chicken pox. Dr. at ER gave her hydroxyzine to help treat symptoms.
redness came up many days later and as of 17 days after the injection I still have redness on that shoulder
Chills - 2 days joint pain - 2-3 days (extreme) nausea/lack of energy - 1-1 1/2 weeks.
5:20PM 'SOB, DIZZY, THROAT TIGHT'.  PLACED ON COT WITH HEAD ELEVATED. CONTINUES TO HAVE SOB. 5:30PM STATES 'FEELING BETTER'. 5:40PM BECOMING SOB AGAIN. 5:55PM  INCREASED SOB/DYSPNEA- SQUAD CALLED. IV ATTEMPT X3 WITHOUT SUCCESS.  6:30PM TRANSPORTED TO ER VIA SQUAD, A/O X3, PINK, W/D, SEVERE DYSPNEA. (2-19-21 3PM TC PT RELEASED FROM HOSPITAL THIS AM. FULL RECOVERY .)
24 hours after receiving the vaccine, muscle spasms began in right forearm, lasting 1 hr, then moved to muscle spasms in right shin and right scapula, each lasting about an hour. Within 48 hours, nausea, headache and general body aches set in.  Muscle spasms ceased, body general malaise and nausea continues into 5 days post vaccine.
Patient's mom received COVID-19 vaccination. She asked if her child could also be vaccinated. Adult dose of Pfizer given.
inconsolable crying for 4 hrs post DTP, OPV, HIBTITER #1;
chills; body aches; muscle weakness; This case was reported by a consumer via call center representative and described the occurrence of chills in a 56-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 14th November 2019, the patient received Shingrix. In November 2019, 12 hrs after receiving Shingrix, the patient experienced chills, general body pain and muscle weakness. On an unknown date, the outcome of the chills, general body pain and muscle weakness were unknown.   It was unknown if the reporter considered the chills, general body pain and muscle weakness to be related to Shingrix.  Additional case details were reported as follows: The patient received vaccine on day before reporting. The patient experiencing chills, body aches, and muscle weakness. The patient enquired whether to take 2nd shot and what is the time. The reporter consent to follow up.
Pt had onset of Dizzines, sweating, and feeling weak post vaccine at about 1140a, pcp was notified. Pt had vitals obtained and proceeded to have evaluation post vaccine reaction at site. Pcp directed MA to call 911, as PCP with assist of other NP obtain vitals. Pt presented at onset of reaction with hypotension that improved with Trendelenburg positioning on exam table as symptoms began to improve with B/P returning to baseline. Pt had ekg that noted NSR on. EMT arrived on site and gather information but Pt declined transport. Pt was able to sit upright and he was encourage fluids orally and tolerated well. Pt educated to increase fluid intake today and tomorrow and if onset of symptoms re-present such as dizziness, weakness, or change from baseline to call 911 and to have evaluation in er. Pt urged to forgo second vaccine administration due to post vaccine symptoms presented this day. Pt daughter arrived on scene and educated pertaining plan of care. Pt and daughter agrees to plan of care.
Information has been received from a physician concerning a female who on 5/13/03 was vaccinated with varicella virus vaccine live. On 11/29/03 the patient developed a mild case of chicken pox. It was noted that the patient's father had broke out with shingles the same day that she broke out with chicken pox. The patient sought unspecified medical attention. There was no product quality complaint involved. Additional information has been requested.
Pt received Gardasil injection in lower right back area on 5/4/07. The next week she noticed enlarged lymphnodes in her right groin area. It was painful when she walked and she noticed some itching in the area. Pt was reassured about the lymphnodes in her right groin area. No info could be found on Lymphandenopathy. Pt will monitor her lymph nodes for the next few weeks. If they increase in size will consider doing an ultrasound. It is most likely they will decrease in size and eventually disappear over the next few months.
Itching on the injection site (left arm); swelling on the injection site (left arm); 2 lymph nodes on right side of her neck; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching on the injection site (left arm)), VACCINATION SITE SWELLING (swelling on the injection site (left arm)) and LYMPHADENOPATHY (2 lymph nodes on right side of her neck) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itching on the injection site (left arm)), VACCINATION SITE SWELLING (swelling on the injection site (left arm)) and LYMPHADENOPATHY (2 lymph nodes on right side of her neck). At the time of the report, VACCINATION SITE PRURITUS (Itching on the injection site (left arm)), VACCINATION SITE SWELLING (swelling on the injection site (left arm)) and LYMPHADENOPATHY (2 lymph nodes on right side of her neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. The patient put ice on injection site due to swelling and itching.
Abdominal pain  within 5 min after vaccine & urticaria 10-15 min after vaccine.  Used BENADRYL with relief.
Preterm labor . 3 weeks early baby was 7lbs 3oz & now I have bell palsy
His mother was present and told us he had multiple allergies to foods and sulfites, as well as asthma. He used to carry an epi pen but does not currently, also has a history of asthma for which he carries a rescue inhaler. He received the Pfizer vaccine at approximately 9:15am in his left deltoid, and about 2 minutes later Mom notified me and the school nurse that he was starting to get "hives". I noted a localized, small area of erythema on his left upper arm around the bandaid, approximately silver dollar sized, not raised. School RN removed the bandaid. He did not complain of itching and at that time stated he felt like he was breathing fine. The school RN gave him 50mg of Benadryl PO per the mom's request at 0920. The patient was in no distress, breathing and speaking normally. At 0922 he stated he felt like his throat and tongue were swelling, so I had him remove his mask, and asked mom if his lips looked swollen to which she responded "yes". He stated it felt like it was hard to swallow. We placed a pulse ox on the patient and his oxygen saturations were 96-100%, HR 85-90, RR 30. We administered an adult epi pen (0.3mg of epinephrine) into his left lateral thigh at 0923 and had the school office call EMS. The patient remained in no acute distress, and said the swelling in his tongue felt better after the epi, but that his throat still felt swollen. Lungs clear bilaterally, RR remained 24-30, HR 110-115, pulse ox 98-100%, erythema on left upper arm resolved. Fire department arrived at 0935- report given and they checked a pulse ox as well. Patient walked to parking lot to ambulance for transfer to Hospital with mother following behind.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 15Feb2021 as dose 1, single (Lot number: EL9266), in left arm, on 18Mar2021 as dose 2, single (Lot number: EW6246), in left arm and on 08Nov2021 as dose 3 (booster), single (Lot number: 3203080) at the age of 45 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "general allergies" (unspecified if ongoing); "interstitial cystitis" (unspecified if ongoing); "Known allergies: sulfa based drugs" (unspecified if ongoing); "Known allergies: shellfish" (unspecified if ongoing). Concomitant medication(s) included: SPIRIVA RESPIMAT, start date: Apr2019; ARNUITY ELLIPTA, start date: Aug2021. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: First day of paxlovid, extreme nausea. Next day, followed with bitter taste in mouth. Throughout felt dizzy and woozy. Ae treatment: zofran for nausea only. Patient received the paxlovid for COVID, treatment start date was 30Jul2022 and treatment stop date was 03Aug2022.  No follow-up attempts are possible. No further information is expected.
Entire arm hurt terribly /Painful; redness and heat at site injection; redness and heat at site injection; This case was reported by a consumer and described the occurrence of pain in arm in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date).   In February 2020, the patient received the 2nd dose of Shingrix. In February 2020, immediately after receiving Shingrix, the patient experienced pain in arm, injection site erythema and injection site warmth. On an unknown date, the outcome of the pain in arm was recovering/resolving and the outcome of the injection site erythema and injection site warmth were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm, injection site erythema and injection site warmth to be related to Shingrix.  Additional details were provided as follows: The patient stated that, received a dose of Shingrix 48 hours ago from the date of reporting. The patient experienced painful immediately after vaccination. The patient stated that, after vaccination, the entire arm was hurt terribly, and also had injection site redness and heat. The patient reported that the arm  pain was slowly subsiding but the redness and heat at site injection has continued to grow. This case linked with case US2020AMR033849 reported by same reporter.
Arm pain PM of 7/21/11 continued and intense during evening & night. 4 weeks still arm pain & weakness.
Headache, Myalgia, Nausea Vomiting, injection site pain/redness/swelling/itching, headaches,  muscle/body aches, fatigue, and nausea. Reports has not fully recovered from side effects.
About two weeks later, I started having significant pain in my left hip joint; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (About two weeks later, I started having significant pain in my left hip joint) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 02SL20A and 032L20A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), ATORVASTATIN and ATENOLOL for an unknown indication.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (About two weeks later, I started having significant pain in my left hip joint). At the time of the report, ARTHRALGIA (About two weeks later, I started having significant pain in my left hip joint) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication not provided. Concomitant drug is given as Olm ned flesh hctz 40-25 but drug code was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 17-Aug-2021: follow up received and Patient street address and city  and Postal code and Date of birth details was added, patient info added, Drug information added, concomitant drugs added
patient got extra dose of shingrix vaccine. completed series in 2020.  no adverse event, just an extra dose of vaccine administered
developed hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (developed hives) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced URTICARIA (developed hives). At the time of the report, URTICARIA (developed hives) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Patient was in bed B in this particular room which is closer to the window, and patient chart given to us had patient in bed A which is closer to the door. Patient already had her 2nd dose of the Pfizer vaccine on our previous visit 3 weeks ago. Pharmacist administered to patient in bed A and ended up being her 3rd dose. No adverse effects reported, patient was monitored for 2 hours and had no signs or symptoms.
vaccinated with RECOMBIVAX, PEDIARIX (manufacturer unknown) PREVNAR 13 (manufacturer unknown) and ROTATEQ during the same office visit/Patient received 2 doses of hepatitis B vaccine; No adverse symptoms reported; Information has been received from a nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies, current condition and concomitant medication were not provided.  On an unknown date the patient was vaccinated with hepatitis b vaccine (recombinant) (RECOMBIVAX HB) (strength, dose, route, batch/lot number and expiration date were not provided), rotavirus vaccine, live, oral, pentavalent(ROTATEQ) (strength, dose, batch/lot number and expiration date were not provided) orally, diphtheria toxoid, hepatitis b virus vaccine rhbsag (yeast), pertussis acellular 3-component vaccine, poliovirus vaccine inactivated (vero), tetanus toxoid(PEDIARIX) (strength, dose, route, batch/lot number and expiration date were not provided) and pneumococcal 13v conj vaccine (crm197)(PREVNAR 13) (strength, dose, route, batch/lot number and expiration date were not provided), all for prophylaxis during a same office visit (overdose). No adverse symptoms reported (no adverse event).
Blood clots in nasal discharge recognized about 36 hours after 1/2 dose booster was administered.  Blood tinged nasal discharge was evident (in gradually decreasing quantities) for 2 days
The first shot, I did not have any reactions. It was like it didn't happen. However, when I got the 2nd dose, the injection site was swollen and red for 2 days. At the week and a half mark, I felt like I had covid. My chest was tight, I couldn't smell, I couldn't taste, and I was fatigued. I felt every symptom. I was told I had to take 14 days off of work and was not pleased about that. I was having body aches. Everything hurt. When I tried to change the channel on the remote, and it hurt. I was coughing and everything felt like a chore. It was so hard to do anything. I was coughing up foam. Towards the end, I started getting a more solid cough. It was pea-sized yellow chunks. There was no blood. It was never green or clear. Everything was either white or off white. It felt a lot like pneumonia. My oxygen was slightly down. I was not okay. I was doing really great and then all of a sudden I couldn't hardly get from the bathroom to the bed. It was a drastic and sudden change in my abilities. I have never had hip problems before and I appeared to have an infection. I was having to go to the chiropractor and get regular adjustments. They put me on an antibiotic and that caused the inflammation to go down. I get winded pretty easily. I am not back to work. I am still not well. I get tired really easily. I am going to physical therapy. I didn't have an injury. The only thing in my life that changed was that I got the vaccine. I know that I did not contract covid because my test was negative. I started into menopause and my periods were coming every 27 days exactly. After the vaccine, my periods were a whole lot worse. I was bleeding so much that I was going through a pad an hour. It was unmanageable. It hasn't really tapered off at all. I am passing huge clots. The OBGYN can not find anything wrong that could be causing it. All of my labs came back totally normal. I never went to the ER. I was told not to go anywhere or do anything. I was told to stay home.
I became covered in red hives especially on my neck, torso front and back as well as to a lesser degree on my arms and legs. I have had hive reactions before so I started a course of benadryl OTC I have at home . Next day I called my MD & couldn't be seen. Went to Urgent Care where MD there had me carry on with Benadryl and wrote RX for dose pack of Methylprednisolone tablets 4mg. I chose not to take the prednisone as by the time I got them too late to take all 6  1st dose so just took benedryl & got better in 5 days. I don't think I'll take the followup 2nd vaccine for shingles.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Mild, Systemic: Weakness-Mild, Additional Details: OXYGEN WAS 98, TEMP WAS 99.1, BP WAS 111/65
Patient received pneumococcal vaccine prior to being discharged following a cardiac surgery. Patient re-hospitalized 2 days after receiveing vaccine with fever of 104 degrees. It was discovered that the patient had a localized, warm, erythematous rash about 4" around the injection site (R arm). Patient treated emirically with cefazolin.  09/10/2007 MR received for DOS 8/26-30/2007 for DX of R arm cellulitis. Pt presented with fever and pain at the injection site as well as some neck pain related to his recent surgery. On hospital day #2 it was noted that the vax site was erythematous,  swollen, warm, and tender. TXd with abx with good response.
Chronic fatigue syndrome symptoms; This is a spontaneous report from a contactable healthcare professional, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Jul2021 at 15:00 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 25Jul2021, the patient experienced chronic fatigue syndrome symptoms. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of event chronic fatigue syndrome symptoms was not resolved at the time of the report.
1 1/2" raised hard knot, very red, itching. "Looked like golfball under the skin" stated by Dad. This was (L) leg, anterior lateral thigh at the Proquad site. On Fri, May 25, babysitter reported to Dad it was worse, (softball size) put ice on till dr could see it. By that time was back to golf ball size. Dr told them to keep ice on it. Dad also applied 1% hydrocortisone. By 5-29 had decreased to small marble size with burising and tender but improving. Subsequently, on an unspecified date, the patient recovered. It was unspecified if a product quality complaint was involved.  02/19/2010 In follow up information, it was reported that on 31-JUL-2007, the patient's mother stated that the patient was fine-no lasting effects. Outcome  was reported as: 31-JUL-2007- Full recovery. Not further information is available.
I received the Moderna COVID 19 vaccine on January 29, 2021.  On the night of February 7, 2021, I noticed a redness on the upper left arm, where I received the injection.  At first, it extended 5 inches by 10 inches.  As of today (February 12, 2021), it is about 6 inches by about 10 inches.  Sometimes, it felt warm to the touch and itched a little.  It seemed redder before I took my evening shower than at other times of day.  It was never painful to the touch. I contacted my primary care physician, on Tuesday February 9 2021, and had a visual virtual examination.  Dr. recommended that I apply an ice pack to the affected area 3 times a day for 5 minutes at t time and also that I take Tylenol 3 times a day. This morning (February 12, 2021), I went in to the doctor?s office for a follow-up, where the nurse prescribed IC Cephaleixin capsules (500 mg), to be taken 4 times a day.  For now, we are continuing to monitor the condition of my arm.
Pt recvd Engerix-B on the following dates 17MAR92, 15MAY92 & exp inject site pain, fever, sweating, chills; not feeling well (mildly flu-like);
Arm throbbing, chills, uncontrollably shaking and convulsions, migrane headache, body aches, muscle aches, hurts to breathe, walk, eat, etc. numbing of limbs, unable to open and close hands, extremely tired and lethargic
THE PATIENT SUDDENLY FAINTED, FELL TO THE FLOOR FROM A SITTING POSITION
Tinnitus began in both ears, but stronger in the right ear the same evening, approx. 2-3 hours after vaccination. As of this date (Dec 9, 2022) the tinnitus has not resolved. It is stronger in the right ear. It is nonstop.  Note that tinnitus was experienced with 1st/2nd dose of the Pfizer COVID vaccine in Spring of 2021, but had resolved after about 8 months, prior to the 3rd (booster) injection. Refer to VAERS ID: 1656053 E-Report Number: 629587
After two hours sore arm ... left side of face slightly numb proceeded by a sharp pain down leg following by an unnatural involuntary movement of toes for about 2 minutes sharp pain then stiffness and inability to move . Numbness followed  by a release and weakness .
Within 2 days after Td, pt had large welts approx 4 inches below injection site.  Welts formed 3" x6" band.  Arm swollen in this area.  Bruising @ inj site.  Very painful, couldn't lift arm or sleep on L side.  Swelling resolved by time of visit to nurse 6 days later.  On date of visit 12/13 arm itchy, no redness or swelling.  Bruise deep red, 4 cm diameter, yellowing approx 2cm on edges.
Significant left arm swelling at site of PNEUMOVAX. Fever last night, also when swelling began (5-10-10). Vaccine administered early am. 14 cm circumferential redness. Tx-ASA 2 po QID and elevate/moist heat.